Press Releases

Nasdaq Biotech ETF (AMEX: IBB) Reverses Trend

Long thought to be down and out, the Nasdaq Biotech ETF (AMEX: IBB) seems to have changed course.



Chart Courtesy of StockCharts.com


Biotech has been the no respect sector for a long time. Ever since the genomics craze fizzled the sector has been full of one hit wonders and lots of disappointment.

Thus, the nice bounce registered on April 1st, caught our attention. To be sure, there is probably not a whole lot that's new in the way of drug development or immunological testing.

After all, with Medicare funding cuts hitting the drug sector, it's hard for drug companies and related areas of the business to get too excited about the future.

Yet, there is always activity in biotech, as start ups and established names can whip up a frenzy at any moment when new things develop.

Or maybe, these stocks have been so abandoned for so long that they look cheap to big money guys looking to put their cash hordes to work after a pretty aggressive, albeit fairly short bear market leg.

What's really important is that a good momentum sector, biotech, seems to be getting some play all of a sudden. And that means that it's worth tuning into the action there.

“Futures And Options For Dummies,” Dr. Duarte’s latest book is now available. The markets are responding to news and geopolitical developments like never before. In this environment, individual investors need to expand their investment horizons. "Futures And Options For Dummies " (John Wiley & Sons) has an excellent section on oil futures as well as the currency markets, while covering and expanding on the successful strategies in Doctor Duarte's other books. Order your copy today.

Doctor Joe Duarte's Market I.Q., offers subscribers a unique blend of intelligence, market commentary and trading strategy. Duarte's daily articles, and news summaries offer recommendations and analysis for ETFs, and individual stocks in the technology, health and biotechnology, and energy sectors. Doctor Duarte is a writer, and an emerging futurist, with a diverse background, and a growing audience. His combined expertise in health care, energy, and the effects of politics and global intelligence on the financial markets offer a unique blend of insight and information to thousands of active investors and political and intelligence aficionados around the world on a daily basis.

He is the author of four books: "Futures And Options For Dummies," "Successful Energy Sector Investing," "Successful Biotech Investing" and co-author of "After-Hours Trading Made Easy."

In early 2001 Dr. Duarte in "Successful Energy Sector Investing," correctly predicted that Venezuela's political problems could lead to an energy crisis in the United States.

In 2003, also Dr. Duarte was among the first to widely publicize the long-term friendship between French President Jacques Chirac and Saddam Hussein.

He has also appeared as a weekly guest on Market Mavens Radio, has logged appearances on KNX radio in Los Angeles, Financial Sense.com radio, and Wall Street Radio.

One of CNBC's original Market Mavens, Dr. Duarte has been writing about the financial markets since 1990.

His articles and commentary have been featured on CBS Marketwatch, Barron's, Smart Money, Medical Economics, and in Technical Analysis of Stocks and Commodities magazines.

In 2003, Doctor Duarte received second place, in the professional section, of the Medical Economics Investment Challenge with a 12-month return of 42%.